Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway Journal Article
| Authors: | Eisenberg, D. P.; Carpenter, S. G.; Adusumilli, P. S.; Chan, M. K.; Hendershott, K. J.; Yu, Z.; Fong, Y. |
| Article Title: | Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway |
| Abstract: | Background: Oncolytic herpes simplex virus-1 (HSV-1) is designed to specifically infect, replicate in, and lyse cancer cells. This study investigates a novel therapeutic regimen, combining the effects of NV1066 (a recombinant HSV-1) and hyperthermia in the treatment of pancreatic cancer. Methods: NV1066 is an attenuated HSV-1 that replicates in cells resistant to apoptosis. Heat shock protein 72 (Hsp72) is a member of a family of proteins that is upregulated after hyperthermic insult, lending cellular protection by inhibiting apoptosis. In these experiments, we test the hypothesis that increased Hsp72 expression in response to hyperthermia enhances anti-apoptotic mechanisms, thereby increasing viral replication and tumor cell kill. Hs 700T pancreatic cancer cells were treated with hyperthermia alone (42°C), NV1066 alone, and combination therapy. Cell survival and viral growth were measured. The effect of siRNA-directed Hsp72 knockdown was also measured. Results: Combining hyperthermia and viral treatment produced a synergistic effect on cell kill. Viral growth increased greater than 6-fold in the presence of hyperthermia (P < .05). Hyperthermia alone showed minimal cytotoxic activity against Hs 700T cells, while NV1066 infection resulted in approximately 50% cell kill. The combination of hyperthermia and viral infection significantly increased cell kill to approximately 80% (P < .01). Hsp72 knockdown attenuated this synergistic effect. Conclusion: Hyperthermia enhances NV1066 replication, thereby potentiating the viral oncolytic response against pancreatic cancer cells. This finding has potential clinical application in the use of heated perfusion or permissive hyperthermia for delivery of oncolytic viral therapies. © 2010 Mosby, Inc. |
| Keywords: | controlled study; protein expression; human cell; genetics; multimodality cancer therapy; pancreas cancer; combined modality therapy; pancreatic neoplasms; metabolism; cell death; cell survival; apoptosis; small interfering rna; rna, small interfering; cytotoxicity; pathology; cell line, tumor; physiology; virology; drug antagonism; nucleotide sequence; cancer cell; pancreas tumor; tumor cell line; tumor cell; oncolytic virus; herpes virus; oncolytic virotherapy; base sequence; cytolysis; herpesvirus 1, human; upregulation; virus infection; gene silencing; virus recombinant; virus replication; dna primers; hyperthermic therapy; primer dna; hyperthermia; hyperthermia, induced; cell protection; herpes simplex virus 1; gene knockdown techniques; virus attenuation; virogenesis; heat shock protein 72; hsp72 heat-shock proteins |
| Journal Title: | Surgery |
| Volume: | 148 |
| Issue: | 2 |
| ISSN: | 0039-6060 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2010-08-01 |
| Start Page: | 325 |
| End Page: | 334 |
| Language: | English |
| DOI: | 10.1016/j.surg.2010.05.005 |
| PUBMED: | 20633729 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "CODEN: SURGA" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
25Yu -
775Fong -
497Adusumilli -
25
Chan
Related MSK Work